SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)
Austria · Delayed Price · Currency is EUR 14.42
+0.08 (0.56%)
At close: Jan 30, 2026
VIE:1SXP Revenue
In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M EUR with 3.04% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 247.58M in the quarter ending September 30, 2025, with 4.44% growth.
Revenue
986.21M
Revenue Growth
+3.04%
P/S Ratio
2.21
Revenue / Employee
209.12K
Employees
4,811
Market Cap
2.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PORR AG | 6.21B |
| Wienerberger AG | 4.64B |
| Mayr-Melnhof Karton AG | 3.99B |
| Österreichische Post AG | 3.11B |
| DO & CO Aktiengesellschaft | 2.40B |
| Palfinger AG | 2.30B |
| AT & S Austria Technologie & Systemtechnik Aktiengesellschaft | 1.64B |
| Flughafen Wien Aktiengesellschaft | 1.11B |